Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2025
Chastre Biolab from Chastre, company number BE0685992413, closed financial year 2025 with a result of € 158,927 after tax. For that financial year Chastre Biolab recorded a gross margin of € 238,903 and equity of € 456,412. Compared with financial year 2024, the result moved from € 118,925 to € 158,927. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 8, 2026.
€ 456,412
▼ 17% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 158,927
▲ 34% vs 2024
Profit after tax over the fiscal year.
€ 466,026
▲ 10% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 250,000 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
€ 9,011
▲ € 8,463 vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 252
▲ 5% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 972
▼ 76% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 194,328 | € 230,028 | € 178,453 | € 238,903 | ▲ 34% |
| Profit after taxes | € 125,868 | € 151,619 | € 118,925 | € 158,927 | ▲ 34% |
| Equity | € 276,941 | € 428,560 | € 547,485 | € 456,412 | ▼ 17% |
| Total debts | € 205,375 | € 86,475 | € 4,346 | € 139,371 | ▲ € 135,025 |
| Cash | € 319,583 | € 376,837 | € 425,339 | € 466,026 | ▲ 10% |
| Land & buildings | € 10,990 | € 9,411 | € 7,831 | € 6,251 | ▼ 20% |
| Retained profit | € 258,341 | € 409,960 | € 528,885 | € 437,812 | ▼ 17% |
| Dividend | € 200,000 | € 0 | € 0 | € 250,000 | |
| Balance sheet total | € 482,316 | € 515,035 | € 551,831 | € 595,783 | ▲ 8% |
Key figures of Chastre Biolab, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Chastre Biolab?
What happened at Chastre Biolab in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 158,927 (▲ 34% vs 2024). Source: NBB ↗
- New establishment in Chastre. KBO
- Start of the company according to the CBE. KBO
In short
From € 125,868 profit in 2022 to € 158,927 profit in 2025.
Paid € 176,696 in corporate taxes since 2022.
Best year ever: 2025, with € 158,927 profit.
Paid out € 450,000 in dividends to the owners in total.
Management
Behind Chastre Biolab is Anne-Sophie Tancre.
Directors
According to the 2025 annual accounts
Anne-Sophie Tancre
Director
Establishments
Establishment units
Physical locations of this company
Rue du Grand Pré 19
1450 Chastre
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0685.992.413
- VAT number
- BE 0685.992.413
- Registered office
- Rue du Grand Pré 19, 1450 Chastre
- Names & denominations
- Chastre Biolab
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 15 December 2017
- Peppol
- Not registered
- Contact
- [email protected]